VTCN1 and neoplasm: The biological activity of B7-H4 is associated with a reduced inflammatory CD4 T cell response, and the correlation between tumor-associated macrophages expressing B7-H4 and regulatory T cells (Tregs) expressing FoxP3 in the tumor microenvironment [14].